3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
23
Squamous Cell Carcinoma of Head and Neck
14
Head and Neck Neoplasms
12
Lung Neoplasms
10
Uterine Cervical Neoplasms
9
Neoplasms
9
Cholangiocarcinoma
5
Carcinoma, Squamous Cell
5
Carcinoma
5
Mesothelioma, Malignant
4
Carcinoma, Hepatocellular
4
Tongue Neoplasms
3
Small Cell Lung Carcinoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Interventions
zimberelimab
1
Radiation
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Pharyngeal Neoplasms
×
Cisplatin
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn